Lim Jonathan E
SEC insider (Form 3/4/5 filer). CIK 0001283290. Director at Boundless Bio, Inc. (BOLD) and 2 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Lim Jonathan E has filed insider reports for
- Boundless Bio, Inc. (BOLD): Director
- Maze Therapeutics, Inc. (MAZE): Director
- Erasca, Inc. (ERAS): Director, Officer, 10% Owner, Chairman & CEO
Lim Jonathan E
CIK: 0001283290
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 15, 2026BOLD
Boundless Bio, Inc.
AwardDirectStock Option (right to buy)
48K shares- - Jun 8, 2026MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
18K shares- - Jan 29, 2026ERAS
Erasca, Inc.
AwardDirectStock option (right to buy)
2M shares- - Sep 22, 2025MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
18K shares- - Jun 23, 2025BOLD
Boundless Bio, Inc.
AwardDirectStock Option (right to buy)
24K shares- - Feb 3, 2025ERAS
Erasca, Inc.
AwardDirectStock option (right to buy)
2.5M shares- - Feb 3, 2025MAZE
Maze Therapeutics, Inc.
ConversionIndirect270.2K shares- - Feb 3, 2025MAZE
Maze Therapeutics, Inc.
ConversionIndirect37.7K shares- - Dec 9, 2024MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
5.7K shares- - Dec 9, 2024MAZE
Maze Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
5.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  BOLD Boundless Bio, Inc. | Award Stock Option (right to buy) | 48,000 | - | - | Direct |
| Jun 8, 2026 |  MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| Jan 29, 2026 |  ERAS Erasca, Inc. | Award Stock option (right to buy) | 2,000,000 | - | - | Direct |
| Sep 22, 2025 | MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| Jun 23, 2025 | BOLD Boundless Bio, Inc. | Award Stock Option (right to buy) | 24,000 | - | - | Direct |
| Feb 3, 2025 | ERAS Erasca, Inc. | Award Stock option (right to buy) | 2,500,000 | - | - | Direct |
| Feb 3, 2025 | MAZE Maze Therapeutics, Inc. | Conversion | 270,232 | - | - | Indirect |
| Feb 3, 2025 | MAZE Maze Therapeutics, Inc. | Conversion | 37,724 | - | - | Indirect |
| Dec 9, 2024 | MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 5,704 | - | - | Direct |
| Dec 9, 2024 | MAZE Maze Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 5,704 | - | - | Direct |
1-10 of 11 transactions